Cai 2003.
Methods |
Study design: randomized controlled trial, parallel group Unit of analysis: eyes Number randomized: 42 total, 21 per group Number of arms: 2 Enrollment start year: 2000 Length of follow‐up: 10 months Sample size calculations: not reported Losses to follow‐up: none |
|
Participants |
Country: China Age (mean (SD, range)): not reported Females (n (%)): 32 (76) total, 18 (82) in the MMC group, 14 (70) in the DCR alone group Inclusion criteria: diagnosis of primary chronic dacryocystitis Exclusion criteria: not reported |
|
Interventions |
Intervention: DCR with application of 0.2 mg/mL MMC Comparison intervention: DCR alone |
|
Outcomes |
Measured outcomes:
Adverse events: none |
|
Identification |
Author name: S Cai Institution: Department of Ophthalmology, Kunshan No. 1 People's Hospital Email: not reported |
|
Notes |
Funding source: not reported Declarations of interest: not reported Trial registration number: not reported |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | High risk | Not randomized by sequence, just by order of visitation. |
Allocation concealment (selection bias) | High risk | Random sequence generation was by order of visitation, therefore treatment allocation was not concealed de facto. |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | Masking of participants or study personnel was not reported. |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | Authors mentioned that "all measurements were taken by the same physician in double‐blinded controlled fashion". |
Incomplete outcome data (attrition bias) All outcomes | Low risk | No missing data reported. |
Selective reporting (reporting bias) | Unclear risk | No trial or protocol registration available for comparison to ascertain selective outcome reporting. |
Other bias | Unclear risk | There was insufficient information to permit a judgement of 'low risk' or 'high risk'. |